Catheter Precision raises $2.82 million in unregistered sale of Series C-4 preferred stock
Reuters2026/07/31 21:21- Catheter Precision closed a private placement of 2,821 shares of Series C-4 Convertible Preferred Stock for gross proceeds of USD 2.82 million.
- The securities carry a stated value of USD 1,000 per share; the closing occurred on July 30, 2026.
- Net proceeds earmarked for working capital, general corporate purposes, and redemption of all outstanding Series B Convertible Preferred Stock.
- Dawson James Securities acted as placement agent; the sale relied on Section 4(a)(2) and Rule 506(b) exemptions.
- Series C-4 Preferred ranks senior to common stock; conversion into common stock would dilute existing holders.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Xenia Hôtellerie Solution announces extraordinary shareholder meeting
Community Reacts As Pundit Claims XRP Will Be Priced At $2,953 By Q2 2027
Colgate-Palmolive (CL.US) plans to sell part of its personal care brands, with a total transaction amount possibly exceeding 1.1 billions USD.
According to sources familiar with the matter, Colgate is exploring the sale of some of its mass-market personal care brands. The company currently plans to divest only a few brands within its personal care business, and the combined sale price may exceed 1 billion dollars.
EdiliziAcrobatica announces shareholder meeting notice
Crypto prices
More
